These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma. Garin MC; Highland KB; Silver RM; Strange C J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563 [TBL] [Abstract][Full Text] [Related]
3. [The role of cardiopulmonary exercise testing in the assessment of pulmonary hypertension]. Dumitrescu D; Rosenkranz S Dtsch Med Wochenschr; 2008 Oct; 133 Suppl 6():S176-9. PubMed ID: 18814090 [TBL] [Abstract][Full Text] [Related]
4. [The effect of Lomir (isradipine) on the tolerance for physical loading and on the gas exchange indices of patients with primary pulmonary hypertension]. Chazova IE; Belenkov IuN; Mareev VIu; Floria VG; Sinitsyn VE; Nakonechnikov SN Ter Arkh; 1994; 66(9):54-7. PubMed ID: 7992215 [TBL] [Abstract][Full Text] [Related]
5. [Lung function and exercise tolerance in patients with chronic major vessel thromboembolic pulmonary hypertension]. Zieliński J; Torbicki A; Filipecki S; Czernicka-Cierpisz E; Sliwiński P; Pruszczyk P; Tobiasz M; Tomkowski W Pneumonol Alergol Pol; 1996; 64(9-10):679-86. PubMed ID: 8991565 [TBL] [Abstract][Full Text] [Related]
6. Comparison of 6-min walk test distance and cardiopulmonary exercise test performance in children with pulmonary hypertension. Lammers AE; Diller GP; Odendaal D; Tailor S; Derrick G; Haworth SG Arch Dis Child; 2011 Feb; 96(2):141-7. PubMed ID: 20930016 [TBL] [Abstract][Full Text] [Related]
7. Six-minute walk test in scleroderma-associated pulmonary arterial hypertension: are we counting what counts? Pamidi S; Mehta S J Rheumatol; 2009 Feb; 36(2):216-8. PubMed ID: 19208554 [No Abstract] [Full Text] [Related]
8. Measurement properties of the 6-min walk test in individuals with exercise-induced pulmonary arterial hypertension. Fowler RM; Jenkins SC; Maiorana AJ; Gain KR; O'Driscoll G; Gabbay E Intern Med J; 2011 Sep; 41(9):679-87. PubMed ID: 21470356 [TBL] [Abstract][Full Text] [Related]
13. Impact of pulmonary hypertension on gas exchange and exercise capacity in patients with pulmonary fibrosis. Gläser S; Noga O; Koch B; Opitz CF; Schmidt B; Temmesfeld B; Dörr M; Ewert R; Schäper C Respir Med; 2009 Feb; 103(2):317-24. PubMed ID: 18804360 [TBL] [Abstract][Full Text] [Related]
14. Differences in hemodynamic parameters and exercise capacity between patients with pulmonary arterial hypertension and chronic heart failure. Nishio R; Tanaka H; Tsuboi Y; Kinutani H; Taniguchi Y; Shigeru M; Toh R; Miura Y; Sakai Y; Emoto N; Kawai H; Hirata K J Cardiopulm Rehabil Prev; 2012; 32(6):379-85. PubMed ID: 23143688 [TBL] [Abstract][Full Text] [Related]
15. Cardiopulmonary Exercise Testing in Pulmonary Hypertension. Weatherald J; Farina S; Bruno N; Laveneziana P Ann Am Thorac Soc; 2017 Jul; 14(Supplement_1):S84-S92. PubMed ID: 28375670 [TBL] [Abstract][Full Text] [Related]
16. Use of non-invasive haemodynamic measurements to detect treatment response in precapillary pulmonary hypertension. Lee WT; Brown A; Peacock AJ; Johnson MK Thorax; 2011 Sep; 66(9):810-4. PubMed ID: 21700759 [TBL] [Abstract][Full Text] [Related]
17. The impact of gas exchange measurement during exercise in pulmonary sarcoidosis. Kollert F; Geck B; Suchy R; Jörres RA; Arzt M; Heidinger D; Hamer OW; Prasse A; Müller-Quernheim J; Pfeifer M; Budweiser S Respir Med; 2011 Jan; 105(1):122-9. PubMed ID: 20926272 [TBL] [Abstract][Full Text] [Related]
18. Aerobic exercise capacity in COPD patients with and without pulmonary hypertension. Pynnaert C; Lamotte M; Naeije R Respir Med; 2010 Jan; 104(1):121-6. PubMed ID: 19577458 [TBL] [Abstract][Full Text] [Related]